It is therefore reasonable to hypothesize that downregulation of miR-375 results in enhanced expression of 14-3-3zeta and SP1 and provides a survival advantage for cancer cells, in contrast, upregulation of miR-375 diminishes the expression of 14-3-3zeta and SP1 and leads to cellular senescence. Here, SP1 is linked to cancer.